Free Trial

Vincerx Pharma (VINC) SEC Filings & 10K Form

Vincerx Pharma logo
$0.04 -0.01 (-15.14%)
As of 07/3/2025 12:54 PM Eastern

Recent Vincerx Pharma SEC Filings

DateFilerForm TypeView
06/18/2025
3:18 PM
Vincerx Pharma (Filer)
Form DEFA14A
05/15/2025
2:13 PM
ARMISTICE CAPITAL, LLC (Filed by)
Vincerx Pharma (Subject)
Form SCHEDULE 13G/A
05/12/2025
3:49 PM
Vincerx Pharma (Filer)
Form DEF 14A
05/04/2025
11:15 PM
Vincerx Pharma (Filer)
Form EFFECT
05/04/2025
11:15 PM
Vincerx Pharma (Filer)
Form EFFECT
05/04/2025
11:15 PM
Vincerx Pharma (Filer)
Form EFFECT
05/01/2025
4:06 PM
Vincerx Pharma (Filer)
Form POS AM
05/01/2025
4:07 PM
Vincerx Pharma (Filer)
Form POS AM
05/01/2025
4:08 PM
Vincerx Pharma (Filer)
Form POS AM
05/01/2025
4:10 PM
Vincerx Pharma (Filer)
Form S-8 POS
05/01/2025
4:11 PM
Vincerx Pharma (Filer)
Form S-8 POS
05/01/2025
4:11 PM
Vincerx Pharma (Filer)
Form S-8 POS
05/01/2025
4:12 PM
Vincerx Pharma (Filer)
Form S-8 POS
05/01/2025
4:13 PM
Vincerx Pharma (Filer)
Form S-8 POS
04/30/2025
3:41 PM
Vincerx Pharma (Filer)
Form PRE 14A
04/17/2025
3:52 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2025
3:03 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2025
11:15 PM
Vincerx Pharma (Filer)
Form EFFECT
03/31/2025
3:02 PM
Vincerx Pharma (Filer)
Form S-3/A
03/18/2025
8:02 AM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2025
8:05 AM
Vincerx Pharma (Subject)
Form 425
02/12/2025
7:30 AM
Prosight Management, LP (Filed by)
Vincerx Pharma (Subject)
Form SCHEDULE 13G/A
02/11/2025
6:09 PM
Long Focus Capital Management, LLC (Filed by)
Vincerx Pharma (Subject)
Form SCHEDULE 13G/A
02/06/2025
3:05 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2025
3:06 PM
Vincerx Pharma (Filer)
Form DEFA14A
01/29/2025
3:05 PM
Vincerx Pharma (Filer)
Form DEFA14A
01/23/2025
3:10 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2025
3:13 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2025
3:15 PM
Vincerx Pharma (Filer)
Form DEFA14A
01/21/2025
3:31 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
3:29 PM
Vincerx Pharma (Filer)
Form 424B5
01/16/2025
4:11 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
3:12 PM
Vincerx Pharma (Filer)
Form 424B5
12/27/2024
3:13 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/25/2024
4:05 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
10:57 AM
BANK OF AMERICA CORP /DE/ (Filed by)
Vincerx Pharma (Subject)
Form SC 13G/A
11/13/2024
7:32 AM
Prosight Management, LP (Filed by)
Vincerx Pharma (Subject)
Form SC 13G/A
11/05/2024
8:15 AM
Vincerx Pharma (Filer)
Form PRE 14A
09/30/2024
5:57 AM
Vincerx Pharma (Subject)
Form SC TO-I/A
09/10/2024
3:02 PM
Vincerx Pharma (Subject)
Form SC TO-I/A
08/16/2024
3:01 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Is Elon's empire crumbling? (Ad)

The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.

Click here to see the Tesla shock that could blindside everyone.
08/14/2024
7:11 PM
THOMAS TOM C (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:00 PM
Izumi Raquel E. (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:03 PM
Seelenberger Alexander A. (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:07 PM
Hamdy Ahmed MD (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
3:37 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
3:39 PM
Vincerx Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/08/2024
3:45 PM
Vincerx Pharma (Filer)
Form DEF 14A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VINC) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners